These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Current concepts in vascular cognitive impairment and pharmacotherapeutic implications. Rojas-Fernandez CH; Moorhouse P Ann Pharmacother; 2009 Jul; 43(7):1310-23. PubMed ID: 19584390 [TBL] [Abstract][Full Text] [Related]
9. [Modern therapy for dementia]. Padberg F; Möller HJ; Bottlender R; Hampel H MMW Fortschr Med; 2005 May; 147 Spec No 2():71-4, 76-7. PubMed ID: 15968877 [TBL] [Abstract][Full Text] [Related]
10. [The action of memantine on the cognitive disorders of patients with dementia: reflections following two years' experience in Spain]. Robles-Bayón A Rev Neurol; 2006 Mar 1-15; 42(5):288-96. PubMed ID: 16538592 [TBL] [Abstract][Full Text] [Related]
12. Caffeine for the prevention and treatment of postdural puncture headache: debunking the myth. Halker RB; Demaerschalk BM; Wellik KE; Wingerchuk DM; Rubin DI; Crum BA; Dodick DW Neurologist; 2007 Sep; 13(5):323-7. PubMed ID: 17848873 [TBL] [Abstract][Full Text] [Related]
13. When should drug treatment be started for people with dementia? Singh B; O'Brien JT Maturitas; 2009 Mar; 62(3):230-4. PubMed ID: 19201114 [TBL] [Abstract][Full Text] [Related]
14. Donepezil treatment of patients with MCI: a 48-week randomized, placebo-controlled trial. Doody RS; Ferris SH; Salloway S; Sun Y; Goldman R; Watkins WE; Xu Y; Murthy AK Neurology; 2009 May; 72(18):1555-61. PubMed ID: 19176895 [TBL] [Abstract][Full Text] [Related]
15. Anticholinesterasics in the treatment of cognitive impairment in multiple sclerosis. Porcel J; Montalban X J Neurol Sci; 2006 Jun; 245(1-2):177-81. PubMed ID: 16674980 [TBL] [Abstract][Full Text] [Related]
17. Eight-year prescription trends of memantine and cholinesterase inhibitors among persons 65 years and older in Germany. Hoffmann F; van den Bussche H; Glaeske G; Kaduszkiewicz H Int Clin Psychopharmacol; 2010 Jan; 25(1):29-36. PubMed ID: 19934763 [TBL] [Abstract][Full Text] [Related]
18. Galantamine treatment of cognitive impairment in bipolar disorder: four cases. Schrauwen E; Ghaemi SN Bipolar Disord; 2006 Apr; 8(2):196-9. PubMed ID: 16542191 [TBL] [Abstract][Full Text] [Related]
19. Migraine with aura is a risk factor for cardiovascular and cerebrovascular disease: a critically appraised topic. Wingerchuk DM; Spencer B; Dodick DW; Demaerschalk BM Neurologist; 2007 Jul; 13(4):231-3. PubMed ID: 17622918 [TBL] [Abstract][Full Text] [Related]
20. Treatment of dementia and cognitive impairment: what can we learn from the Cochrane Library. Bereczki D; Szatmári S J Neurol Sci; 2009 Aug; 283(1-2):207-10. PubMed ID: 19268303 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]